Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniela Bertens
Observed name:
Bertens, Daniela
Institution:
Patagonian Ecosystems Investigation Research Center
Observed institutions:
Amsterdam Neuroscience,
Patagonian Ecosystems Investigation Research Center,
Amsterdam UMC Location Vrije Universiteit Amsterdam
ORCID:
0000-0003-2271-762X
Observed ORCID:
0000-0003-2271-762X
OpenAlex ID:
A5080627652
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial
2017
·
Hilkka Soininen
, Alina Solomon
, et al.
·
The Lancet Neurology
·
286
PDF
Mild cognitive impairment
2017
·
Pieter Jelle Visser
, Nienke Legdeur
, et al.
·
Oxford University Press eBooks
·
107
Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population
2017
·
Daniela Bertens
, Betty M. Tijms
, et al.
·
Alzheimer s Research & Therapy
·
102
PDF
Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's disease
2014
·
Daniela Bertens
, Dirk L. Knol
, et al.
·
Alzheimer s & Dementia
·
78
Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey
2019
·
Daniela Bertens
, Stephanie Vos
, et al.
·
Alzheimer s Research & Therapy
·
54
PDF
The effect of diagnostic criteria on outcome measures in preclinical and prodromal Alzheimer's disease: Implications for trial design
2017
·
Daniela Bertens
, Betty M. Tijms
, et al.
·
Alzheimer s & Dementia Translational Research & Clinical Interventions
·
29
PDF
Low normal cerebrospinal fluid Aβ42 levels predict clinical progression in nondemented subjects
2017
·
Betty M. Tijms
, Daniela Bertens
, et al.
·
Annals of Neurology
·
29
Research diagnostic criteria for Alzheimer’s disease: findings from the LipiDiDiet randomized controlled trial
2021
·
Anna Rosenberg
, Alina Solomon
, et al.
·
Alzheimer s Research & Therapy
·
9
PDF
Effect of helium on cerebral blood flow: A n=1 trial in a healthy young person
2012
·
Sanne M. Zinkstok
, Daniela Bertens
, et al.
·
Perspectives in Medicine
·
4
PDF
The use of biomarkers in non-demented AD patients for clinical trial design and clinical practice
2021
·
Daniela Bertens
·
Pure Amsterdam UMC
·
2
O4‐01‐05: Use of biomarkers as endpoint in trials with subjects with preclinical and prodromal Alzheimer's disease: An ADNI study
2012
·
Daniela Bertens
, Philip Scheltens
, et al.
·
Alzheimer s & Dementia
·
1
PDF
Monitoreo de flora vascular en microcuencas de montaña de Aysén
2026
·
Paulo Moreno Meynard
, Yall Asenie
, et al.
·
Global Biodiversity Information Facility
P4‐112: Amyloid Levels in the Normal Range are Predictive for Incident Dementia in Non‐Demented Elderly
2016
·
Betty M. Tijms
, Daniela Bertens
, et al.
·
Alzheimer s & Dementia
P4‐040: Use of recent research criteria for inclusion and use of biomarkers as endpoint in preclinical and prodromal Alzheimer's disease (AD) trials: An Alzheimer's disease neuroimaging initiative (ADNI) study
2015
·
Daniela Bertens
, Betty M. Tijms
, et al.
·
Alzheimer s & Dementia
O5‐02‐04: Vascular and Clinical Correlates of Microbleeds in Prodromal Ad
2014
·
Elles Konijnenberg
, Daniela Bertens
, et al.
·
Alzheimer s & Dementia
O3–03–05: Temporal evolution of biomarkers and cognitive markers from preclinical to clinical Alzheimer's disease: An Alzheimer's Disease Neuroimaging Initiative (ADNI) study
2013
·
Daniela Bertens
, Philip Scheltens
, et al.
·
Alzheimer s & Dementia
PDF
Show more works
View as search
Works count:
23
Citation count:
701
H-index:
8
I10-index:
7
Year
Topic
Type